Y
Yuichi Inoue
Researcher at Tokyo Medical University
Publications - 300
Citations - 8265
Yuichi Inoue is an academic researcher from Tokyo Medical University. The author has contributed to research in topics: Sleep disorder & Obstructive sleep apnea. The author has an hindex of 42, co-authored 279 publications receiving 6729 citations. Previous affiliations of Yuichi Inoue include Tottori University.
Papers
More filters
Journal ArticleDOI
A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia
TL;DR: In this paper, the authors conducted a meta-analysis focusing on the effect of CBT-I on subjective sleep parameters and self-rating scales, and found that CBT was more effective than the control for subjective sleep variables at the end of treatment and its effectiveness was also recognized on follow-up.
Journal ArticleDOI
The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
Diego Garcia-Borreguero,Ralf Kohnen,Michael H. Silber,John W. Winkelman,John W. Winkelman,Christopher J. Earley,Christopher J. Earley,Birgit Högl,Mauro Manconi,Jacques Montplaisir,Yuichi Inoue,Richard P. Allen,Richard P. Allen +12 more
TL;DR: The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLP symptoms, cognitive status, history, and comorbid conditions.
Journal ArticleDOI
Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory.
Misa Takegami,Yoshimi Suzukamo,Takafumi Wakita,Hiroyuki Noguchi,Kazuo Chin,Hiroshi Kadotani,Yuichi Inoue,Yasunori Oka,Takaya Nakamura,Joseph Green,Murray W. Johns,Shunichi Fukuhara +11 more
TL;DR: In Japan, the developer-authorized Japanese version of the Epworth Sleepiness Scale provides reliable and valid information on daytime sleepiness and researchers who use the ESS with other populations should combine their knowledge of local conditions with the results of psychometric tests.
Journal ArticleDOI
Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder
TL;DR: It is demonstrated that markedly reduced cardiac 123I-metaiodobenzylguanidine uptake is reported, consistent with the loss of sympathetic terminals, in idiopathic RBD, and this reduction is of the same magnitude as that found in patients with Parkinson disease.
Journal ArticleDOI
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Diego Garcia-Borreguero,Michael H. Silber,John W. Winkelman,Birgit Högl,Jacquelyn L. Bainbridge,Mark J. Buchfuhrer,Georgios M. Hadjigeorgiou,Yuichi Inoue,Mauro Manconi,Wolfgang H. Oertel,William G. Ondo,Juliane Winkelmann,Richard P. Allen +12 more
TL;DR: Treatment of existing augmentation should be initiated, where possible, with the elimination/correction of extrinsic exacerbating factors (iron levels, antidepressants, antihistamines, etc.).